|Articles|October 1, 2011
- Pharmaceutical Executive-10-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - October 2011
Thirty Years of Pharm Exec
Advertisement
Articles in this issue
almost 15 years ago
Y. K Hamied : Changing the Dialoguealmost 15 years ago
Fred Frank: Fortune and the Financieralmost 15 years ago
Marck McLellan: An 'A' for Advancing Expectationsalmost 15 years ago
Inside the Mind of the CEO: Steve Collisalmost 15 years ago
Atsushi Nagahisa: Creating Customer Valuealmost 15 years ago
Physicians: Still the Vital Connection in Medicinealmost 15 years ago
Henry Waxman: "Representing" Healthcare to the Fullestalmost 15 years ago
IP: Securing a Global Consensus—Can Industry Do It Again?almost 15 years ago
In Establishing the Evidence Base, He Made Science Countalmost 15 years ago
Jane Henney: Lessons from the FDA Front LineAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5